Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1 16Phase 2/3 5Phase 3 3Phase NA 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Leukemia, Myeloid, Acute 2Gastrointestinal Stromal Tumors 2Recurrence 1

Interventions

Cyclophosphamide 22fludarabine phosphate 17Cyclosporine 15Peripheral Blood Stem Cell Transplantation 14Methotrexate 14Filgrastim 14Whole-Body Irradiation 11Mycophenolic Acid 11Busulfan 11Antilymphocyte Serum 11Radiotherapy 8Melphalan 8Exercise 8Dexamethasone 8Cytarabine 8Asparaginase 8venetoclax 7blinatumomab 7Vincristine 7Etoposide 7Daunorubicin 7fludarabine 6Methylprednisolone 6Mercaptopurine 6Granulocyte Colony-Stimulating Factor 6Therapeutics 5Psychiatric Rehabilitation 5Prednisone 4Immunotherapy, Adoptive 4Cord Blood Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Dasatinib × Clear all
NCT05024357 2021-10-01

A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Unknown
80 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05026229 2021-10-01

A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Unknown
60 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡